Browsing publications by Professor Olaf Heidenreich

Newcastle AuthorsTitleYearFull text
Judith Weiland
Dr Deepali Pal
Marian Case
Dr Julie Irving
Dr Frida Ponthan
et al.
BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance2016
Dr Deepali Pal
Dr Helen Blair
Dr Alex Elder
Katie Dormon
Dr Kate Rennie
et al.
Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia2016
Dr Alex Elder
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Katie Dormon
et al.
The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.2016
Dr Victoria Forster
Mohammed Nahari
Dr Natalia Martinez Soria
Amy Bradburn
Dr Sarah Fordham
et al.
The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype2016
Professor Olaf Heidenreich
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO2016
Dr Paul Sinclair
Joanna Cheng
Prahlad Raninga
Rebecca Hanna
Shaun Hollern
et al.
A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM12015
Katie Dormon
Elda Latif
Dr Matthew Bashton
Dr Deepali Pal
Dr Helen Blair
et al.
A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse2015
Judith Weiland
Dr Alex Elder
Dr Victoria Forster
Professor Olaf Heidenreich
Professor Josef Vormoor
et al.
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia2015
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Dr Lisa Russell
Professor Olaf Heidenreich
et al.
Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier2015
Professor Olaf Heidenreich
Professor Anthony Moorman
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options2015
12345678910111213